Gale Scott

Patients with atrial fibrillation (AFib) have an increased risk of death when they take digoxin, a risk that increases with dosage, a study found.

Researchers sought to change the volume of fatty deposits in a coronary artery that was at least 30% blocked.

The researchers vaccinated known contacts of people with newly diagnosed Ebola infection. Some were vaccinated immediately, some not for 21 days. In all, there were 2,151 people vaccinated.

Drug candidate can treat individuals who have PTSD associated with their military service.

Sitagliptin (Januvia/Merck) helps manage diabetes patients admitted hospital for general medical problems or surgery.

A diet with foods rich in magnesium may reduce rates of cardiovascular disease, type 2 diabetes, and all-cause mortality.

Cox-2 inhibitors carry risk for arthritis patients with heart disease.

Tenofovir-alafenamide combination approved by the FDA for chronic hepatitis B infection.

Dolutegravir/abacavir shows a solid safety profile and a high barrier to resistance.

Obstacles exist in making testing and treatment for hepatitis C routine practice in prison.

Coinfection with HIV plus a hepatitis B, C, or both, adds to the risk of non-Hodgkins lymphoma.

Lucentis treats wet age-related macular degeneration and macular edema after retinal vein occlusion.

Many patients wait until after becoming infected with HIV to seek treatment.

Ultrasound not deemed to be sufficiently sensitive to detect early stage liver cancer.

Canagliflozin and metformin hydrochloride extended release (Invokamet) improves blood glucose control in adults with type 2 diabetes.

Canagliflozin with extended release formulation of metformin improves blood glucose control in type 2 diabetes.

Navigating prior authoization requirements for patients coinfected with hepatitis C and HIV remains a challenge.

Restarting infliximab after discontinuation can still be effective in ulcerative colitis, however.

Decision will make direct-acting antivirals available to 40% of the state's estimated 60,000 Medicaid patients with chronic HCV.

A typcial treatment regimen for hepatitis C virus lasts 12 weeks at a high cost.

Novel drug RG-101 could shorten the treatment time for hepatitis C virus (HCV) infection to 4 weeks.

Zepatier achieves sustained virologic response rate of 99.2% during a 12 to 16 week treatment course in patients with HCV.

Mifepristone is now approved for use up to 70 days after the first day of a woman's last menstrual period.

Adding tiotropium bromide inhalation spray to other asthma therapies improved lung function and symptom control.

Research explores treatment of drug users with hepatitis C virus (HCV) infection with direct-acting antivirals.

Most MS patients have not considered changing their diet as a therapeutic approach.

Most new cases of hepatitis C infection in New York City found in the baby boomer generation.

Acceptance is a multiple sclerosis treatment goal because it is associated with better drug adherence.

Fingolimid is an oral treatment for relapsing-remitting multiple sclerosis.

Fingolimid is an oral treatment for relapsing-remitting multiple sclerosis.